Suppr超能文献

[儿童呼吸道感染肺炎克雷伯菌中质粒介导的AmpCβ-内酰胺酶耐药性检测及基因型分析]

[Detection of drug resistance due to the plasmid-mediated AmpC β-lactamase and genotype analysis in Klebsiella pneumoniae resulting in respiratory infections in children].

作者信息

Lin Ping

机构信息

Department of Pediatrics, Medical School, Taizhou University, Taizhou, Zhejiang 318000, China.

出版信息

Zhonghua Er Ke Za Zhi. 2011 Dec;49(12):921-5.

Abstract

OBJECTIVE

To investigate the production and AmpC β-lactamase in Klebsiella (K.) pneumoniae resulting in respiratory infections in children, AmpC β-Lactamase genotypic resistance and typical resistance to common antibiotics so as to provide some references for selecting drugs in clinical treatment.

METHOD

Microbiological identification was performed with the VITEK 60 System, extended spectrum β lactamases (ESBLs) were detected in accordance with the confirmatory test recommended by Clinical and Laboratory Standards Institute (CLSI) and drug sensitivity was determined with Kirby-Bauer method. Suspected positive strains of AmpC β-lactamase were screened with cefoxitin disk diffusion. The genotypes were analyzed by cefoxitin three-dimensional test, conjugation test and PCR sequencing.

RESULT

Of the 135 isolates, 30.37% were ESBLs positive, 15.56% were AmpC β-lactamase positive. The positive rates for only AmpC β-Lactamase, both AmpC β-Lactamase and ESBLs, and only ESBLs were 8.15%, 7.41% and 22.96% respectively. The resistant genotypes for AmpC β-Lactamase-positive strains was that 19 strains were of DHA-1 type and 2 were of ACT-1 type. The resistance to drugs in β-lactamase-producing strains was obviously higher than that in non-β-lactamase-producing strains and more serious in those strains producing both AmpC β-Lactamase and ESBLs. Sensitivity of β-lactamase, non-β-lactamase and ESBLs producing strains to imipenem was as high as 100 percent.

CONCLUSION

ESBLs- and AmpC-β-lactamase-producing strains of K. pneumoniae resulting in respiratory infections in children in Taizhou city, have a higher detection rate in Taizhou and AmpC-β-lactamase is mainly of DHA-1 genotype. AmpC-β-lactamase- and ESBLs-producing strains are highly resistant, so to restrict the use of β-lactam antibiotics is an important step to reduce the epidemic of β-lactamase-producing strains infection.

摘要

目的

研究导致儿童呼吸道感染的肺炎克雷伯菌中AmpCβ-内酰胺酶的产生情况、AmpCβ-内酰胺酶基因型耐药性及对常用抗生素的耐药情况,为临床治疗选药提供参考依据。

方法

采用VITEK 60系统进行微生物鉴定,按照美国临床和实验室标准协会(CLSI)推荐的确证试验检测超广谱β-内酰胺酶(ESBLs),采用 Kirby-Bauer法进行药敏试验。用头孢西丁纸片扩散法筛选可疑AmpCβ-内酰胺酶阳性菌株,通过头孢西丁三维试验、接合试验及PCR测序分析基因型。

结果

135株分离菌中,ESBLs阳性率为30.37%,AmpCβ-内酰胺酶阳性率为15.56%。仅AmpCβ-内酰胺酶阳性、AmpCβ-内酰胺酶和ESBLs均阳性、仅ESBLs阳性的比例分别为8.15%、7.41%和22.96%。AmpCβ-内酰胺酶阳性菌株的耐药基因型中,19株为DHA-1型,2株为ACT-1型。产β-内酰胺酶菌株对药物的耐药性明显高于非产β-内酰胺酶菌株,且产AmpCβ-内酰胺酶和ESBLs的菌株耐药情况更严重。产β-内酰胺酶、非产β-内酰胺酶及产ESBLs菌株对亚胺培南的敏感性均高达100%。

结论

泰州市导致儿童呼吸道感染的肺炎克雷伯菌中产ESBLs和AmpCβ-内酰胺酶菌株检出率较高,AmpCβ-内酰胺酶主要为DHA-1基因型。产AmpCβ-内酰胺酶和ESBLs菌株耐药性高,限制β-内酰胺类抗生素的使用是减少产β-内酰胺酶菌株感染流行的重要措施。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验